Obstetrics & Gynecology Doctors in Bellmore, NY Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Dr. Annie Frenkel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2428 Merrick Rd, Bellmore, NY 11710 Phone: 516-379-2689

Dr. Howard G Nathanson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2428 Merrick Rd, Bellmore, NY 11710 Phone: 516-379-2689    Fax: 516-992-8380

Mrs. Melissa Beth Glasser Caine, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2428 Merrick Road, Bellmore, NY 11710 Phone: 516-379-2689    Fax: 516-992-8380

Douglas R Phillips, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2428 Merrick Rd, Bellmore, NY 11710 Phone: 516-379-2689    Fax: 516-992-8380

Ronnie Marsha Salzman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2428 Merrick Rd, Bellmore, NY 11710 Phone: 516-379-2689    Fax: 516-992-8320

Lauren Michele Bashian, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2428 Merrick Rd, Bellmore, NY 11710 Phone: 516-379-2689

Dr. Laura Carinci, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2750 Merrick Rd, Bellmore, NY 11710 Phone: 516-409-2000    Fax: 516-409-2720

News Archive

SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval from the Chinese State Food and Drug Administration ("SFDA) for the production of generic Omeprazole Sodium injections.

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy

While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.

Mitomics introduces new test to detect prostate cancer

Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.

Researchers receive €2.35 million to examine disease pathways of viruses

Two University College Dublin (UCD) researchers and SiriusXT, a UCD spin-out company, have been awarded a total of €2.35 million in funding for a disruptive photonics technology project, through Horizon 2020, the EU's research and innovation programme, to examine the disease pathways of viruses.

Read more Medical News

› Verified 3 days ago